伏立康唑在播散性侵袭性曲霉病中的心包和胸膜扩散：一例成功治愈病例报告 - Suppr

Suppr

超能文献

Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.

作者信息

Poupelin J C, Philit F, Richard J C, Badet M, Lemasson S, Bayle F, Guérin C

出版信息

Intensive Care Med. 2006 Jun;32(6):939-40. doi: 10.1007/s00134-006-0113-x. Epub 2006 Mar 11.

DOI:10.1007/s00134-006-0113-x

PMID:16532330

Abstract

摘要

相似文献

Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.

Intensive Care Med. 2006 Jun;32(6):939-40. doi: 10.1007/s00134-006-0113-x. Epub 2006 Mar 11.

Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.

Prescrire Int. 2004 Feb;13(69):13-6.

[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].

Presse Med. 2006 Feb;35(2 Pt 1):251-2. doi: 10.1016/s0755-4982(06)74566-3.

[Experience with voriconazole in invasive aspergillosis].

Mycoses. 2003;46 Suppl 2:3-7.

Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

Antimicrob Agents Chemother. 2004 Mar;48(3):1065. doi: 10.1128/AAC.48.3.1065.2004.

Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.

Pediatrics. 2006 Aug;118(2):e506-8. doi: 10.1542/peds.2005-2213. Epub 2006 Jun 30.

[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].

Enferm Infecc Microbiol Clin. 2009 Mar;27(3):193-4. doi: 10.1016/j.eimc.2008.01.002. Epub 2009 Feb 13.

Oral voriconazole for invasive fungal skull base infection.

J Laryngol Otol. 2010 Sep;124(9):1010-3. doi: 10.1017/S0022215109992507. Epub 2009 Dec 23.

Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.

Antimicrob Agents Chemother. 2000 Oct;44(10):2865-8. doi: 10.1128/AAC.44.10.2865-2868.2000.

Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.

J Pediatr Hematol Oncol. 2003 Sep;25(9):732-4. doi: 10.1097/00043426-200309000-00011.

引用本文的文献

Fungal Pericarditis-A Systematic Review of 101 Cases.

Microorganisms. 2025 Mar 21;13(4):707. doi: 10.3390/microorganisms13040707.

Empyema Thoracis at Two Academic Medical Centers: New Insights Into Treatment and Outcomes.

Open Forum Infect Dis. 2021 Apr 17;8(4):ofaa656. doi: 10.1093/ofid/ofaa656. eCollection 2021 Apr.

Anidulafungin Pharmacokinetics in Ascites Fluid and Pleural Effusion of Critically Ill Patients.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02326-17. Print 2018 Apr.

Acute lymphocytic leukemia with superimposed invasive aspergillosis and pneumopericardium successfully treated with voriconazole.

Proc (Bayl Univ Med Cent). 2014 Jul;27(3):250-2. doi: 10.1080/08998280.2014.11929128.

Tissue penetration of antifungal agents.

Clin Microbiol Rev. 2014 Jan;27(1):68-88. doi: 10.1128/CMR.00046-13.

Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

Antimicrob Agents Chemother. 2011 May;55(5):2478-80. doi: 10.1128/AAC.01560-10. Epub 2011 Mar 14.

Human tissue distribution of voriconazole.

Antimicrob Agents Chemother. 2011 Feb;55(2):925-8. doi: 10.1128/AAC.00949-10. Epub 2010 Nov 15.

本文引用的文献

Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

Antimicrob Agents Chemother. 2004 Mar;48(3):1065. doi: 10.1128/AAC.48.3.1065.2004.

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.

Antimicrob Agents Chemother. 2002 Aug;46(8):2546-53. doi: 10.1128/AAC.46.8.2546-2553.2002.

The clinical spectrum of pulmonary aspergillosis.

Chest. 2002 Jun;121(6):1988-99. doi: 10.1378/chest.121.6.1988.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.

Intensive Care Med. 2006 Jun;32(6):939-40. doi: 10.1007/s00134-006-0113-x. Epub 2006 Mar 11.

Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.

Prescrire Int. 2004 Feb;13(69):13-6.

[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].

Presse Med. 2006 Feb;35(2 Pt 1):251-2. doi: 10.1016/s0755-4982(06)74566-3.

[Experience with voriconazole in invasive aspergillosis].

Mycoses. 2003;46 Suppl 2:3-7.

Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

Antimicrob Agents Chemother. 2004 Mar;48(3):1065. doi: 10.1128/AAC.48.3.1065.2004.

Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.

Pediatrics. 2006 Aug;118(2):e506-8. doi: 10.1542/peds.2005-2213. Epub 2006 Jun 30.

[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].

Enferm Infecc Microbiol Clin. 2009 Mar;27(3):193-4. doi: 10.1016/j.eimc.2008.01.002. Epub 2009 Feb 13.

Oral voriconazole for invasive fungal skull base infection.

J Laryngol Otol. 2010 Sep;124(9):1010-3. doi: 10.1017/S0022215109992507. Epub 2009 Dec 23.

Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.

Antimicrob Agents Chemother. 2000 Oct;44(10):2865-8. doi: 10.1128/AAC.44.10.2865-2868.2000.

Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.

J Pediatr Hematol Oncol. 2003 Sep;25(9):732-4. doi: 10.1097/00043426-200309000-00011.

引用本文的文献

Fungal Pericarditis-A Systematic Review of 101 Cases.

Microorganisms. 2025 Mar 21;13(4):707. doi: 10.3390/microorganisms13040707.

Empyema Thoracis at Two Academic Medical Centers: New Insights Into Treatment and Outcomes.

Open Forum Infect Dis. 2021 Apr 17;8(4):ofaa656. doi: 10.1093/ofid/ofaa656. eCollection 2021 Apr.

Anidulafungin Pharmacokinetics in Ascites Fluid and Pleural Effusion of Critically Ill Patients.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02326-17. Print 2018 Apr.

Acute lymphocytic leukemia with superimposed invasive aspergillosis and pneumopericardium successfully treated with voriconazole.

Proc (Bayl Univ Med Cent). 2014 Jul;27(3):250-2. doi: 10.1080/08998280.2014.11929128.

Tissue penetration of antifungal agents.

Clin Microbiol Rev. 2014 Jan;27(1):68-88. doi: 10.1128/CMR.00046-13.

Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

Antimicrob Agents Chemother. 2011 May;55(5):2478-80. doi: 10.1128/AAC.01560-10. Epub 2011 Mar 14.

Human tissue distribution of voriconazole.

Antimicrob Agents Chemother. 2011 Feb;55(2):925-8. doi: 10.1128/AAC.00949-10. Epub 2010 Nov 15.

本文引用的文献

Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

Antimicrob Agents Chemother. 2004 Mar;48(3):1065. doi: 10.1128/AAC.48.3.1065.2004.

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.

Antimicrob Agents Chemother. 2002 Aug;46(8):2546-53. doi: 10.1128/AAC.46.8.2546-2553.2002.

The clinical spectrum of pulmonary aspergillosis.

Chest. 2002 Jun;121(6):1988-99. doi: 10.1378/chest.121.6.1988.